These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Flutamide-induced diarrhea secondary to lactose intolerance. Yagoda A J Natl Cancer Inst; 1989 Dec; 81(23):1839-40. PubMed ID: 2585531 [No Abstract] [Full Text] [Related]
13. [Effect of change to flutamide for prostate cancer patient who developed breast pain during bicalutamide treatment (BIP-F study)]. Kitamura Y; Okuno H; Sakura Y; Manabe Y; Masuda N; Ito H; Mishina M; Taoka R; Terai A; Sugimoto M; Kakehi Y Hinyokika Kiyo; 2014 Jan; 60(1):17-23. PubMed ID: 24594768 [TBL] [Abstract][Full Text] [Related]
14. 'Zoladex' versus 'Zoladex' plus flutamide in the treatment of advanced prostate cancer. First interim analysis of an international trial. International Prostate Cancer Study Group. Lunglmayr G Prog Clin Biol Res; 1989; 303():145-51. PubMed ID: 2528737 [TBL] [Abstract][Full Text] [Related]
15. [Hepatic encephalopathy induced by flutamide administered for the treatment of prostatic cancer]. Patel H; Rhee E; Zimmern PE J Urol (Paris); 1996; 102(3):123-5. PubMed ID: 9091557 [TBL] [Abstract][Full Text] [Related]
16. A pilot study of flutamide. A new agent in the treatment of advanced prostatic cancer. Sarfaty GA; Alder SJ; McLean RG Med J Aust; 1984 Feb; 140(4):219-21. PubMed ID: 6694625 [TBL] [Abstract][Full Text] [Related]
17. Interstitial pneumonitis related to leuprorelin acetate and flutamide. Azuma T; Kurimoto S; Mikami K; Oshi M J Urol; 1999 Jan; 161(1):221. PubMed ID: 10037405 [No Abstract] [Full Text] [Related]
18. [Hepatotoxicity and flutamide]. Martínez Bruna MS; Velila Alcubilla JP; Abinzano M; Martínez Velasco C; García Mauriz ME; Urbieta Echezareta M An Med Interna; 1993 Nov; 10(11):566. PubMed ID: 8117876 [No Abstract] [Full Text] [Related]
19. [Hepatotoxicity due to flutamide]. Caballería E; Aragó JV; Sanchís A Med Clin (Barc); 1994 Mar; 102(11):434. PubMed ID: 8183002 [No Abstract] [Full Text] [Related]
20. Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss. Preston DM; Torréns JI; Harding P; Howard RS; Duncan WE; McLeod DG Prostate Cancer Prostatic Dis; 2002; 5(4):304-10. PubMed ID: 12627216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]